Press Releases
Quaker Chemical Announces Third Quarter 2018 Results
Mr. Barry continued, "Looking forward to the fourth quarter of the year, we do expect some potential headwinds such as a strong U.S. dollar and higher raw material costs. However, we also anticipate modest growth in our overall base markets similar to the third quarter and expect our volume growth will exceed this due to continued market share gains, which will help offset some of the fourth quarter headwinds we foresee. In addition, we are implementing additional price increases where necessary and expect our gross margins to be in the low to mid 36 percent range. Overall, we expect to continue our year-over-year non-GAAP earnings per diluted share and adjusted EBITDA growth in the fourth quarter. Concerning the Houghton combination, we are making progress with both the U.S. and European regulatory authorities and expect to receive approval and close sometime in December or January. Overall, I continue to be confident in our future given our modestly growing global end markets, our continued market share gains, U.S. Tax Reform and the benefits we will achieve through the upcoming combination with Houghton."
Third Quarter of 2018 Summary
Net sales grew
Gross profit in the third quarter of 2018 increased
SG&A increased
During the third quarter of 2018, the Company incurred
Operating income in the third quarter of 2018 was
Other expense, net, was
Interest expense increased
The Company's effective tax rates for the third quarters of 2018 and 2017 were 18.5% and 22.1%, respectively. Both of these effective tax rates include the impact of Houghton combination-related expenses, noted above, certain of which were considered non-deductible for the purpose of determining the Company's effective tax rate. In addition, the Company recorded a tax adjustment of
Equity in net income of associated companies increased slightly in the third quarter of 2018 compared to the third quarter of 2017, primarily due to higher income from the Company's interest in a captive insurance company.
The Company's net income attributable to noncontrolling interest decreased
Foreign exchange negatively impacted the Company's third quarter of 2018 earnings by approximately 6% or
Year-to-Date 2018 Summary
Net sales grew
Gross profit in the first nine months of 2018 increased
SG&A increased
During the first nine months of 2018, the Company incurred
Operating income in the first nine months of 2018 was
Other expense, net, was
Interest expense increased
The Company's effective tax rates for the first nine months of 2018 and 2017 were 21.2% and 32.5%, respectively. Similar to the third quarter of 2018 summary above, the Company's first nine months of 2018 and 2017 effective tax rates were impacted by the non-deductibility of certain Houghton combination-related expenses. In addition, the current year effective tax rate was impacted by
Equity in net income of associated companies decreased
The Company's net income attributable to noncontrolling interest decreased
Foreign exchange negatively impacted the Company's first nine months of 2018 earnings by less than 1% or
Balance Sheet and Cash Flow Items
The Company's net operating cash flow of
Houghton Combination
On
Non-GAAP Measures
Included in this public release are two non-GAAP (unaudited) financial measures: non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The following tables reconcile non-GAAP earnings per diluted share (unaudited) and adjusted EBITDA (unaudited) to their most directly comparable GAAP (unaudited) financial measures:
Three Months Ended September 30, |
Nine Months Ended |
||||||||
2018 |
2017 |
2018 |
2017 |
||||||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders |
$ 1.47 |
$ 0.83 |
$ 3.87 |
$ 2.25 |
|||||
Equity income in a captive insurance company per diluted share |
(0.03) |
(0.03) |
(0.08) |
(0.11) |
|||||
Houghton combination-related expenses per diluted share (a) |
0.23 |
0.52 |
0.89 |
1.47 |
|||||
Transition Tax adjustments per diluted share (b) |
(0.08) |
— |
(0.17) |
— |
|||||
U.S. pension plan settlement charge per diluted share |
— |
— |
— |
0.09 |
|||||
Cost streamlining initiative per diluted share |
— |
— |
— |
0.01 |
|||||
Gain on liquidation of an inactive legal entity per diluted share |
(0.03) |
— |
(0.03) |
— |
|||||
Currency conversion impacts of hyper-inflationary economies per diluted share |
0.04 |
0.00 |
0.06 |
0.03 |
|||||
Non-GAAP earnings per diluted share |
$ 1.60 |
$ 1.32 |
$ 4.54 |
$ 3.74 |
|||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||
2018 |
2017 |
2018 |
2017 |
||||||
Net income attributable to Quaker Chemical Corporation |
$ 19,690 |
$ 11,142 |
$ 51,668 |
$ 30,040 |
|||||
Depreciation and amortization |
4,883 |
5,017 |
14,911 |
14,954 |
|||||
Interest expense (a) |
1,510 |
793 |
4,804 |
2,229 |
|||||
Taxes on income before equity in net income of associated companies (b) |
4,330 |
3,140 |
13,554 |
14,229 |
|||||
Equity income in a captive insurance company |
(440) |
(400) |
(1,083) |
(1,427) |
|||||
Houghton combination-related expenses (a) |
2,904 |
9,675 |
11,794 |
23,088 |
|||||
U.S. pension plan settlement charge |
— |
— |
— |
1,860 |
|||||
Cost streamlining initiative |
— |
— |
— |
286 |
|||||
Gain on liquidation of an inactive legal entity |
(446) |
— |
(446) |
— |
|||||
Currency conversion impacts of hyper-inflationary economies |
520 |
35 |
764 |
375 |
|||||
Adjusted EBITDA |
$ 32,951 |
$ 29,402 |
$ 95,966 |
$ 85,634 |
|||||
Adjusted EBITDA margin (%) |
14.8% |
13.8% |
14.6% |
14.1% |
(a) |
During the three and nine months ended September 30, 2018, the Company incurred $0.9 million and $2.6 million of interest costs, |
(b) |
Transition Tax adjustments of $1.1 million and $2.3 million during the three and nine months ended September 30, 2018 are |
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, significant changes in applicable tax rates and regulations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us, including factors related to the previously announced pending Houghton combination and the risk that the transaction may not receive regulatory approval or that regulatory approval may include conditions or other terms not acceptable to us. For more information regarding these risks and uncertainties as well as certain additional risks that we face, you should refer to the Risk Factors detailed in Item 1A of our Form 10-K for the year ended
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
|||||||
Condensed Consolidated Statements of Income |
|||||||
(Dollars in thousands, except share and per share data) |
|||||||
(Unaudited) |
|||||||
Three Months Ended |
Nine Months Ended |
||||||
September 30, |
September 30, |
||||||
2018 |
2017 |
2018 |
2017 |
||||
Net sales |
$ 222,022 |
$ 212,918 |
$ 656,039 |
$ 609,010 |
|||
Cost of goods sold |
140,929 |
138,142 |
418,562 |
391,512 |
|||
Gross profit |
81,093 |
74,776 |
237,477 |
217,498 |
|||
% |
36.5% |
35.1% |
36.2% |
35.7% |
|||
Selling, general and administrative expenses |
53,270 |
51,092 |
157,360 |
148,740 |
|||
Combination-related expenses |
2,904 |
9,675 |
12,404 |
23,088 |
|||
Operating income |
24,919 |
14,009 |
67,713 |
45,670 |
|||
% |
11.2% |
6.6% |
10.3% |
7.5% |
|||
Other (expense) income, net |
(523) |
249 |
(631) |
(1,427) |
|||
Interest expense |
(1,510) |
(793) |
(4,804) |
(2,229) |
|||
Interest income |
521 |
762 |
1,581 |
1,825 |
|||
Income before taxes and equity in net income of associated companies |
23,407 |
14,227 |
63,859 |
43,839 |
|||
Taxes on income before equity in net income of associated companies |
4,330 |
3,140 |
13,554 |
14,229 |
|||
Income before equity in net income of associated companies |
19,077 |
11,087 |
50,305 |
29,610 |
|||
Equity in net income of associated companies |
694 |
617 |
1,623 |
2,049 |
|||
Net income |
19,771 |
11,704 |
51,928 |
31,659 |
|||
Less: Net income attributable to noncontrolling interest |
81 |
562 |
260 |
1,619 |
|||
Net income attributable to Quaker Chemical Corporation |
$ 19,690 |
$ 11,142 |
$ 51,668 |
$ 30,040 |
|||
% |
8.9% |
5.2% |
7.9% |
4.9% |
|||
Share and per share data: |
|||||||
Basic weighted average common shares outstanding |
13,278,259 |
13,217,165 |
13,263,417 |
13,196,255 |
|||
Diluted weighted average common shares outstanding |
13,315,541 |
13,251,693 |
13,297,345 |
13,238,073 |
|||
Net income attributable to Quaker Chemical Corporation Common |
$ 1.48 |
$ 0.84 |
$ 3.88 |
$ 2.26 |
|||
Net income attributable to Quaker Chemical Corporation Common |
$ 1.47 |
$ 0.83 |
$ 3.87 |
$ 2.25 |
Quaker Chemical Corporation |
|||
Condensed Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value and share amounts) |
|||
(Unaudited) |
|||
September 30, |
December 31, |
||
2018 |
2017 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 99,810 |
$ 89,879 |
|
Accounts receivable, net |
214,056 |
208,358 |
|
Inventories, net |
96,605 |
87,221 |
|
Prepaid expenses and other current assets |
17,446 |
21,128 |
|
Total current assets |
427,917 |
406,586 |
|
Property, plant and equipment, net |
82,157 |
86,704 |
|
Goodwill |
83,695 |
86,034 |
|
Other intangible assets, net |
65,912 |
71,603 |
|
Investments in associated companies |
22,471 |
25,690 |
|
Non-current deferred tax assets |
15,072 |
15,661 |
|
Other assets |
32,065 |
30,049 |
|
Total assets |
$ 729,289 |
$ 722,327 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 5,673 |
$ 5,736 |
|
Accounts and other payables |
96,053 |
97,732 |
|
Accrued compensation |
24,099 |
22,846 |
|
Other current liabilities |
31,485 |
29,384 |
|
Total current liabilities |
157,310 |
155,698 |
|
Long-term debt |
46,875 |
61,068 |
|
Non-current deferred tax liabilities |
9,543 |
9,653 |
|
Other non-current liabilities |
82,925 |
87,044 |
|
Total liabilities |
296,653 |
313,463 |
|
Equity |
|||
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2018 - 13,334,364 shares; 2017 - 13,307,976 shares |
13,334 |
13,308 |
|
Capital in excess of par value |
96,121 |
93,528 |
|
Retained earnings |
402,255 |
365,182 |
|
Accumulated other comprehensive loss |
(80,332) |
(65,100) |
|
Total Quaker shareholders' equity |
431,378 |
406,918 |
|
Noncontrolling interest |
1,258 |
1,946 |
|
Total equity |
432,636 |
408,864 |
|
Total liabilities and equity |
$ 729,289 |
$ 722,327 |
Quaker Chemical Corporation |
|||
Condensed Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
(Unaudited) |
|||
Nine Months Ended |
|||
September 30, |
|||
2018 |
2017 |
||
Cash flows from operating activities |
|||
Net income |
$ 51,928 |
$ 31,659 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|||
Depreciation |
9,386 |
9,464 |
|
Amortization |
5,525 |
5,490 |
|
Equity in undistributed earnings of associated companies, net of dividends |
2,658 |
(1,919) |
|
Deferred compensation and other, net |
(898) |
(1,190) |
|
Share-based compensation |
2,847 |
3,269 |
|
Gain on disposal of property, plant and equipment and other assets |
(680) |
(50) |
|
Insurance settlement realized |
(680) |
(542) |
|
Combination-related expenses, net of payments |
(349) |
10,367 |
|
Pension and other postretirement benefits |
(1,113) |
608 |
|
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions: |
|||
Accounts receivable |
(14,029) |
(12,946) |
|
Inventories |
(12,719) |
(9,272) |
|
Prepaid expenses and other current assets |
2,196 |
(5,217) |
|
Accounts payable and accrued liabilities |
6,824 |
11,755 |
|
Restructuring liabilities |
- |
(675) |
|
Net cash provided by operating activities |
50,896 |
40,801 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(8,815) |
(8,032) |
|
Payments related to acquisitions, net of cash acquired |
(500) |
(5,363) |
|
Proceeds from disposition of assets |
803 |
67 |
|
Insurance settlement interest earned |
102 |
35 |
|
Net cash used in investing activities |
(8,410) |
(13,293) |
|
Cash flows from financing activities |
|||
Proceeds from long-term debt |
- |
4,472 |
|
Repayments of long-term debt |
(11,518) |
(488) |
|
Dividends paid |
(14,385) |
(13,893) |
|
Stock options exercised, other |
(227) |
(2,594) |
|
Distributions to noncontrolling affiliate shareholders |
(834) |
- |
|
Net cash used in financing activities |
(26,964) |
(12,503) |
|
Effect of foreign exchange rate changes on cash |
(6,168) |
4,758 |
|
Net increase in cash, cash equivalents and restricted cash |
9,354 |
19,763 |
|
Cash, cash equivalents and restricted cash at the beginning of the period |
111,050 |
110,701 |
|
Cash, cash equivalents and restricted cash at the end of the period |
$ 120,404 |
$ 130,464 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/quaker-chemical-announces-third-quarter-2018-results-300742596.html
SOURCE
Mary Dean Hall, Vice President, Chief Financial Officer and Treasurer, Hallm@quakerchem.com, T. 610.832.4160